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Introduction: The use of synthetic patch angioplasty during carotid endarterectomy (CEA) has been advocated to reduce
restenosis, stroke, and death, but the type of material used is still being debated. This study compared rate of restenosis,
neurologic events, and perioperative death in patients undergoing CEA with primary closure versus polyester urethane
patch closure.
Patients and Methods: In a prospective randomized study, we compared patch angioplasty with polyester urethane
(Vascular-patch, B. Braun Medical AG, Tuttlingen, Germany) to primary closure between February 1999 and March
2002 in 404 operations. Early (30-day) stroke and mortality rate, long-term restenosis, and neurologic events were
compared in the two groups during 2.5 to 5 years of follow-up (median follow-up, 2 years).
Results: Primary closure was used in 216 operations, and patch angioplasty was used in 206. Clamping time was
significantly shorter in the primary closure group (P < .001). Perioperative mortality and neurologic events were similar
in both groups (1.9% vs 3.9%, P  .21, odds ratio [OR], 2.1; 95% confidence interval [CI], 0.56 to 9.85). The rate of
residual stenosis (>50%) at 0 or 3-month follow-up was significantly lower in the patch group (2 operations, 1.1%)
compared with the primary closure group (17 operations, 8.9%) (P  .001, OR, 0.114; 95% CI, 0.026 to 0.5).
Multivariable logistic regression showed that only primacy closure was found to influence residual stenosis. Restenosis of
70% was significantly less in the patch angioplasty group (2.2% vs 8.6%) (P  .01, hazard ratio, 0.246; 95% CI, 0.08 to
0.75). No correlation was found between restenosis and gender, preoperative symptoms, or risk factors.
Conclusions: Patch angioplasty with polyester urethane significantly reduced the restenosis rate (P  .01) compared with
primary closure. Even though clamping time was longer, patching was not associated with more perioperative compli-
cations. ( J Vasc Surg 2005;41:403-8.)Carotid endarterectomy is the treatment of choice for
patients with symptomatic and asymptomatic high-grade
carotid stenosis.1-3 The form of arteriotomy closure has
been examined in recent reviews of the Cochrane
Library,4-5 and seven trials comprising 1300 operations
were evaluated to assess the effect of routine or selective
carotid patch angioplasty compared with primary closure.
In these reviews, carotid patch angioplasty showed a reduc-
tion in the risk of stroke and death during the perioperative
period and in long-term follow-up. It also demonstrated a
reduction in perioperative arterial occlusion and decreased
restenosis in long-term follow-up. No difference was found
in the incidence of hemorrhage, infection, cranial nerve
palsies, or pseudo-aneurysm formation.
There is controversy about which patch material is
optimal for use. Currently used materials include autolo-
gous vein, polytetrafluoroethylene (PTFE), polyester, and
bovine pericardium. A recent review of the Cochrane Li-
brary compared different patch materials.6 The differences
found were very small, although one trial found PTFE
patches to be superior to collagen-impregnated Dacron
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Pseudoaneurysms were more common after a vein patch
than with a synthetic patch.
Prosthetic patches are readily available, technically easy
to use, and may reduce the risk for rupture and aneurysmal
dilatation previously reported in saphenous vein patch graft
after carotid endarterectomy.7-9 Infection is a serious pos-
sible complication of synthetic patch angioplasty but can be
treated with reasonable success.10-12
In our review of the literature, we did not find studies
that the evaluated restenosis rate and postoperative compli-
cations after polyester urethane patch angioplasty. To study
these questions, we conducted a prospective randomized
study of polyester urethane patch angioplasty versus pri-
mary closure after CEA.
METHODS
Between February 1999 and March 2002, all patients
undergoing CEA in the Carmel Medical Center vascular
department who consented to participate in this study were
prospectively randomized into two groups (404 patients,
422 operations). Group 1 had primary closure of the arte-
riotomy (216 operations), and group 2 had polyester ure-
thane patch angioplasty (206 operations) (Vascular-patch,
B. Braun Medical AG, Tuttlingen, Germany).
The scrub nurse, using sealed envelopes, did the ran-
domization in the operating room. Twenty-four patients
were excluded because intraoperative findings such as small
diameter internal carotid artery (ICA) or the need for an
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assignation to the two treatment groups.
Preoperative data were age, gender, hypertension, nic-
otine use, ischemic heart disease, diabetes mellitus, hyper-
cholesterolemia/hyperlipidemia, previous vascular surgery,
and a history of carotid symptoms, including stroke, tran-
sient ischemic attack (TIA), silent brain ischemia on com-
puted tomography (CT) scan, and asymptomatic. Results
of preoperative imaging (duplex scanning, CT angiography
[CTA], angiography) were also noted. Intraoperative data,
including systemic and stump pressures, clamping time,
and type of carotid closure were recorded.
All operations were performed under cervical block
unless the patient could not tolerate local anesthesia due to
low compliance (nine patients). An intraluminal shunt was
used in cases of change in neurologic status during carotid
clamping or in patients undergoing general anesthesia with
a stump pressure40 mmHg. Intravenous heparin (5000
U)was administered to all patients before carotid clamping.
After the operation, all patients were monitored for 6
hours in the recovery room and received intravenous hep-
arin (500 U/24 h). All patients received aspirin (100 mg
once daily) pre- and postoperatively and were usually dis-
charged on the second postoperative day.
Postoperative evaluation included a duplex scan at 1, 3,
6, and 12 months, and annually thereafter up to 5 years. All
patients were contacted by telephone to ensure regular
follow-up.
The primary endpoint of this study was the postopera-
tive incidence of residual disease3 months and restenosis
3 months. Secondary endpoints were perioperative mor-
bidity and mortality, and stroke-free and overall survival.
Duplex ultrasound scanning was used as the primary
imaging tool for the determination of residual and recur-
rent carotid stenosis. The duplex study was preformed by
an HDI 3500 and HDI 3000 (Philips) using a 4-7 Mhz
transducer. The patients, ultrasound technicians, and doc-
tors were blinded to the type of arteriotomy closure. In our
noninvasive vascular laboratory, the degree of carotid ste-
nosis is reported as grades 1 to 5:
● Grade 1: 0% to 25%, peak systolic velocity (PSV) of
125 to 130 cm/s, end diastolic velocity (EDV) 40
cm/s.
● Grade 2: 26% to 50%, PSV, 131 to 150 cm/s; EDV
40 cm/s.
● Grade 3: 51% to 70%, PSV, 151 to170 cm/s, EDV
110 cm/s, PSV in the ICA and PSV in the common
carotid artery (CCA) (PSVICA/PSVCCA)  3.2 to 4.
● Grade 4: 71% to 90%, PSV 171cm/s, EDV 110 to
140 cm/s, PSVICA/PSVCCA 4.
● Grade 5: 91% to 99%, EDV 140cm/s, PSVICA/
PSVCCA 4 or string sign.
● Grade 6: occluded. Cases of suspected occlusion were
validated by high-resolution CTA
Recurrent stenosis for this study was defined as luminal
diameter stenosis 70% as diagnosed by follow-up duplex
ultrasound examination. We also reported the recurrentstenosis of 50% because some of the previous studies in
this area have defined restenosis as 50%. No intraopera-
tive before or after CEA imaging was used. The hospital
board of ethics and the ministry of health (HTA 920)
approved this clinical trial.
Statistical analysis. We constructed this study to ad-
dress the main question of residual and recurrent stenosis.
With a recurrent stenosis of about 10% in large controlled
trials,4-6 we calculated that a sample size of 200 in each
group was needed to detect a reduction in restenosis from
10% to 3%.
Binary demographics (gender), baseline risk factors,
and outcome variables (shunt, complications and residual
stenosis) were compared between treatment groups using
the 2 test, the Fisher exact test when appropriate, and odds
ratios (OR) along with 95% confidence interval (CI). Con-
tinuous demographics (age) and outcome variables (clamp
time, stump pressure) were summarized using mean 
standard deviation and were compared between groups by
using the t test.
Survival and restenosis-free proportions were calcu-
lated and presented using Kaplan-Meier survival curves.
The log-rank test was used to test differences between
groups in event-free curves. The multivariate Cox propor-
tional hazard model was used to adjust treatment compar-
isons to demographics and baseline risk factors and to test
interactions.
The unit of observation for the analyses was the oper-
ated artery, except for the demographics and time-to-death
analyses where patients with bilateral operations were con-
sidered at their first procedure. All statistical tests were
two-sided, with a 5% significance level.
Analyses were performed with the Statistical Package
for the Social Sciences (SPSS) (version 11) (SPSS, Inc.) and
Statistical Analysis System (SAS) SAS (version 9.1) (SAS
Institute, Inc.) software.
RESULTS
Four hundred four patients (265 men, 157 women)
underwent 422 procedures. Thirteen (3%) were lost to
follow-up, which ranged from 1 month to 5 years (median,
2 years). Primary closure was used in 216 operations and
patch angioplasty in 206. There was no difference between
the study groups with regard to patients lost to follow-up,
gender, baseline risk factors, or preoperative symptoms.
The mean age was 71  8.5 years in the primary closure
group and 68  9.4 years in the patch angioplasty group.
(P  .002). Preoperative demographics are listed in Table
I.
A shunt was used in 80 operations (51 in the patch
group, 29 in the primary closure group) (P  .003, OR,
2.12; 95% CI, 1.28 to 3.51). The clamping time was
significantly longer (P  .001) for the patch group (35 
11 minutes) versus the primary closure group (23  8
minutes).
Early mortality and morbidity rates. One patient
(0.2%) died during the first postoperative month from a
myocardial infarction. Eleven patients experienced an im-
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tients after primary closure (1 cerebrovascular accident
[CVA], 2 TIA) and 8 patients after patch angioplasty (3
CVA, 5 TIA) (Table II). There was no statistical difference
in the rate of neurologic events between the two groups
(P .21, OR, 2.14; 95% CI, 0.56 to 9.85). The combined
postoperative mortality and stroke rate was 1.2%.
In the primary closure group, two patients underwent
re-exploration. In one patient, a dissection was found at the
arteriotomy site and treated with a vein graft repair. The
other patient had a white clot removed and the artery was
closed with an interposition Gortex graft (WL Gore &
Associates).
Three patients with patch closure underwent re-
exploration. In two, a thrombus was found at the arteriot-
omy site and was removed. One was treated with an inter-
position 6-mm Gortex graft, the other with a Dacron
Table I. Preoperative patient demographic data
Primary closure
n (%)
Patch
n (%) P
Gender* .26
Male 131 (63) 134 (68)
Female 77 (37) 62 (32)
Age (mean  SD) 71  8.5 68  9.4 .002
Smoker 34 (16) 48 (23) .05
Hypertension 155 (72) 146 (71) .84
Diabetes mellitus 74 (34) 76 (37) .57
Dyslipidemia 96 (44) 99 (48) .46
Ischemic heart disease 108 (50) 95 (46) .45
Previous vascular surgery
(CABG, CEA, peripheral
bypass)
72 (33) 71 (34) .8
Preoperative symptoms 0.6
Asymptomatic 109 (51) 108 (52)
Transient ischemic attack 69 (32) 57 (28)
Stroke 38 (18) 41 (20)
CABG, coronary artery bypass graft; CEA, carotid endarterectomy.
*At first surgery for patients with bilateral surgery.
Table II. Immediate postoperative complications
(30-day)
Primary closure Patch closure
Neurologic events
TIA 2 5
Stroke 1 3
Bleeding 3 5
Infection 6 1
Coronary event* 3 0
Cranial nerve damage 7 5
TIA, Transient ischemic attack.
Any complications: P.86 (odds ratio, 0.94; 95% confidence interval, 47 to
1.9).
Any neurologic events: P .21 (odds ratio, 2.14; 95% confidence interval,
0.56 to 9.85).
*All coronary events were myocardial infarctions with elevated troponin
levels.patch. In the third patient, the thrombus was found distalto the patch. The patient was treated by intracarotid uroki-
nase with a subsequent patch angioplasty. The rest of the
symptomatic patients that were not explored had normal
duplex or CT examinations.
One patient with a patch angioplasty had an infected
hematoma and was treated by removal of the synthetic
patch and replacement by a vein patch, with no subsequent
clinical symptoms or restenosis. There was no significant
difference between the two groups in the combined com-
plication rate (9.7% vs 9.2%).
The rate of residual stenosis (50%) at 0 or 3-month
follow-up was significantly lower in the patch group (2
operations, 1.1%) compared with the primary closure
group (17 operations, 8.9%) (P  .001, OR, 0.114; 95%
CI, 0.026 to 0.5). When only multivariable logistic regres-
sion was used, primary closure was found to influence
residual stenosis.
Long-term outcome. Seventy-nine additional pa-
tients (19.6%) died during the 5-year follow-up. The 1-year
overall survival rate, calculated according to the Kaplan-
Meiermethod, was 97.6 1.1 in the primary closure group
and 97  1.2 in the patch group (Fig 1). There was no
statistical difference between the groups in the crude or
age-adjusted overall survival (age-adjusted hazard ratio,
0.87; 95% CI, 0.56 to 1.36; P  .55).
Recurrent stenosis 70% was found in 18 postopera-
tive arteries (5.2%): 14 (8.6%) after primary closure and 4
(2.2%) after patch. According to Kaplan-Meier curves (Fig
2), restenosis-free rates were higher in the patch group (P 
.01, hazard ratio  0.246; 95% CI 0.08 to 0.75). Looking
Fig 1. Kaplan-Meier analysis shows cumulative survival rate for
primary closure and patch angioplasty. Numbers at risk are shown
at 1-year intervals. (Age-adjusted hazard ratio, 0.87; 95% confi-
dence interval, 0.58 to 1.36; P  .55)at the 2-year restenosis-free rate only, it can be seen that the
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compared with 90.9  2.3% in the primary closure group
versus the primary closure group (90.9  2.3) (P  .01,
hazard ratio, 0.246; 95% CI, 0.08 to 0.75). In multivariate
analysis that included baseline risk factors and demograph-
ics, only patch angioplasty was found to influence restenosis
rate. Restenosis 50% was found in 31 arteries (8.9%): 22
(13.6%) after primary closure versus 9 (4.9%) arteries with
patch closure. According to Kaplan-Meier curves (Fig 3),
restenosis-free rates were higher in the patch group (P 
.01, hazard ratio 0.36; 95% CI 0.16 to 0.78). Looking at
the 2-year restenosis-free rate only, it can be seen that the
patch group had a 95.9  1.5% restenosis-free rate as
compared with 86.9  2.8% in the primary closure group.
In the univariate analysis, aside from the patch, only
female gender (P  .09, hazard ratio, 1.8; 95% CI, 0.9 to
3.8) and hypertension (P .05, hazard ratio, 3.4; 95% CI,
1 to 11.3) had borderline significance; however, in multi-
variate analysis, only patch closure retained its significance.
In subgroup analysis, the hazard ratio among men with
patch closure was 0.21 (95% CI, 0.06 to 0.75), whereas in
women, the hazard ratio was 0.71 (95% CI, 0.24 to 2.1);
however, the interaction was not statistically significant
(P .12). When men and women in the patch group were
compared, women had a higher rate of restenosis (P .04,
hazard ratio, 4.2; 95% CI, 1.06 to 16.51).
Only one patient with restenosis was symptomatic (re-
current TIAs).
DISCUSSION
Controversy continues on the benefit of carotid patch
Fig 2. Kaplan-Meier analysis shows significant recurrent stenosis
(50%) free rate for primary closure and patch angioplasty. Num-
bers at risk are shown at 1-year intervals. (Hazard ratio, 0.36, 95%
confidence interval, 0.16 to 0.78; P  .01)angioplasty and the optimal material used.4-6 The rate ofperioperative stroke and TIA in this study was statistically
similar in both primary closure and polyester urethane
patch angioplasty. This differs from previous reports that
suggest a higher rate of perioperative strokes, carotid
thrombosis, and early restenosis with polyester patch
(collagen-impregnated Dacron-Hemashield) compared
with PTFE,15-16 which might be explained by a continued
platelet adhesion up to 9 months after surgery.17
Because postoperative events are relatively rare to
achieve statistic significance, a large randomized trial is
needed. For such a study, 3000 patients will have to be
randomized to have an 80% chance of detecting a 50%
reduction of combined death and stroke rate from 5% to
2.5% between the two groups.13-14
Patch angioplasty tends to take longer and concerns
about postoperative complications after a longer clamping
time have been raised. Although the clamping time was
longer in the patch group, this did not increase the postop-
erative complication rate in this study.
The rate of residual stenosis 50% was significantly
lower after patch angioplasty (1.1 % vs. 8.9%, P  .001).
Intraoperative imaging was not preformed, so we cannot
exclude a technical problem in the closure of the arteriot-
omy. Intraoperative imaging should be considered, espe-
cially in primary closure, to diagnose and correct such
problems.
Restenosis 70% was observed in 18 arteries with a
significant advantage to patch over primary closure (2-year
restenosis-free rate was 97.6% vs 90.9%, P  0.01). The
incidence of 13.6% significant (50%) restenosis in the
primary closure in this study is comparable with the review
Fig 3. Kaplan-Meier analysis shows significant recurrent stenosis
(70%) free rate for primary closure and patch angioplasty. Num-
bers at risk are shown at 1-year intervals. (Hazard ratio, 0.246, 95%
confidence interval, 0.08 to 0.75; P  .01)by the Cochrane library.4 We did not find comparable
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thane patch. Using multivariate Cox regression analysis, we
found that restenosis of50% was associated with primacy
closure (P  0.01).
Previous studies have suggested that recurrent stenosis
might be connected to gender, with a higher rate of reste-
nosis in women.15,19, 22-24 In a study by Ricco et al,18
women with patch closure (knitted polyester patch impreg-
nated with collagen) had a higher rate of restenosis than did
men. This result is similar to the results in this study where
women in the polyester urethane patch group had a higher
rate of restenosis (50%) (P  .04, hazard ratio, 4.2; 95%
CI (1.06 to 16.51). A larger sample size might aid in
further evaluating the interaction between patch and gen-
der, especially in this synthetic patch.
One patient (4.2%) with restenosis was symptomatic.
This finding is similar to the literature19-21 and may be
explained by the gradual development of the restenosis,
usually due to intimal hyperplasia, without macroulcer-
ations that may be responsible for neurologic symptoms in
carotid stenosis caused by arteriosclerosis. The decision on
how to treat patients with recurrent carotid artery stenosis
must be influenced by this and by the high complication
rate of a reoperation. We prefer to treat these patients with
a carotid stent and only when there is a contralateral occlu-
sion or the patients are symptomatic.
In conclusion, this randomized prospective study has
shown that carotid patch angioplasty with a polyester ure-
thane patch has good postoperative results with a low rate
of immediate postoperative complications and, compared
with primary closure, has a much lower rate of restenosis.
We thank Ofra Barnett-Griness, PhD, for help with the
statistical analysis of this study.
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